Our results are the first characterization of this system in the striatum of a genetically accurate mouse model with physiological expression of mutant HTT and provide the first evidence linking TGF‐β and SMAD3 to downstream transcriptomic changes in HD mouse models. The gene discussed is TGFB1; the disease is Huntington disease.